Published Online
on May 5, 2005

A more recent version of this article appeared on June 1, 2005

This Article Full Text (PDF) All Versions of this Article: 36/6/1225    most recent 01.STR.0000166044.06026.46v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Strandberg, T. E. Search for Related Content PubMed PubMed Citation Articles by Strandberg, T. E. Pubmed/NCBI databases Medline Plus Health Information Blood Pressure Medicines High Blood Pressure Stroke Transient Ischemic Attack Related Collections Secondary prevention Related Article

Secondary Prevention of Stroke Is Important. But All Hypertensive Drugs Are Not Created Equal?

Timo E. Strandberg MD, PhD

Helsinki University Central Hospital, Finland

Related Article:

Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention: Principal Results of a Prospective Randomized Controlled Study (MOSES)

Joachim Schrader, Stephan Lüders, Anke Kulschewski, Frank Hammersen, Kerstin Plate, Jürgen Berger, Walter Zidek, Peter Dominiak, Hans Christoph Diener, and the MOSES Study Group
Stroke 2005 36: 1218-1224. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

				L. Lopez-Jimenez, M. Camafort, G. Tiberio, J. A. Carmona, C. Guijarro, F. Martinez-Penalver, M. Monreal, and FRENA Investigators Secondary Prevention of Arterial Disease in Very Elderly People: Results From a Prospective Registry (FRENA) Angiology, August 1, 2008; 59(4): 427 - 434. [Abstract] [PDF]

				R. Oprisiu-Fournier, J.-M. Serot, J.-M. Achard, F. H. Messerli, S. E. Black, and A. Fournier AT1 Receptor Blockers for Cognition Decline After Cardiac Surgery? Stroke, November 1, 2006; 37(11): 2666 - 2666. [Full Text] [PDF]

				A. Fournier, G. Choukroun, S. S. Modeliar, O. Godefroy, J.-M. Achard, J. Wang, and F. Messerli Does the MOSES Trial Establish Superiority of AT1-Receptor Blockers Over Dihydropyridine/Calcium Antagonists in Secondary Stroke Prevention? Stroke, February 1, 2006; 37(2): 336 - 337. [Full Text] [PDF]